Archi Agrawal

7PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)NanomedicineEnvironmental studies in animal production
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 09, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

|Apr 23, 2026
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial.

|Jan 27, 2023
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.

Vijay Maruti Patil, Vanita Noronha, Nandini Menon

|Oct 20, 2022
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.

Vijay Maruti Patil, Vanita Noronha, Nandini Menon

|Sep 19, 2022
Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival.

Akshay S Bedmutha, Archi Agrawal, Venkatesh Rangarajan

|Mar 12, 2020
Renal granulomas mimicking as malignant renal masses on F18 FDG PET/CT in a case of urothelial carcinoma.

Manikandan M V, Archi Agrawal, Santosh Menon

Pageof 2

Frequent Collaborators

4 joint publications

Vanita Noronha

4 joint publications

Nandini Menon

4 joint publications

Kumar Prabhash

2 joint publications

Vijay Patil